MX384485B - Deteccion temprana de preeclampsia. - Google Patents

Deteccion temprana de preeclampsia.

Info

Publication number
MX384485B
MX384485B MX2016012278A MX2016012278A MX384485B MX 384485 B MX384485 B MX 384485B MX 2016012278 A MX2016012278 A MX 2016012278A MX 2016012278 A MX2016012278 A MX 2016012278A MX 384485 B MX384485 B MX 384485B
Authority
MX
Mexico
Prior art keywords
preeclampsia
subject
early detection
anxa2
level
Prior art date
Application number
MX2016012278A
Other languages
English (en)
Spanish (es)
Other versions
MX2016012278A (es
Inventor
Antonio Pellicer
Carlos Simon
Tamara Garrido
Original Assignee
Igenomix S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igenomix S L filed Critical Igenomix S L
Publication of MX2016012278A publication Critical patent/MX2016012278A/es
Publication of MX384485B publication Critical patent/MX384485B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2016012278A 2014-03-21 2015-03-19 Deteccion temprana de preeclampsia. MX384485B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461968728P 2014-03-21 2014-03-21
US201461969520P 2014-03-24 2014-03-24
PCT/IB2015/001404 WO2015166353A2 (en) 2014-03-21 2015-03-19 Early detection of preeclampsia

Publications (2)

Publication Number Publication Date
MX2016012278A MX2016012278A (es) 2017-04-27
MX384485B true MX384485B (es) 2025-03-14

Family

ID=54147245

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016012278A MX384485B (es) 2014-03-21 2015-03-19 Deteccion temprana de preeclampsia.

Country Status (8)

Country Link
US (1) US20170097358A1 (cg-RX-API-DMAC10.html)
EP (1) EP3120152A2 (cg-RX-API-DMAC10.html)
JP (1) JP6684263B2 (cg-RX-API-DMAC10.html)
CN (2) CN110927385A (cg-RX-API-DMAC10.html)
BR (1) BR112016021630A2 (cg-RX-API-DMAC10.html)
CA (1) CA2943284A1 (cg-RX-API-DMAC10.html)
MX (1) MX384485B (cg-RX-API-DMAC10.html)
WO (1) WO2015166353A2 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
BR112016029558A2 (pt) 2014-06-17 2017-08-22 Igenomix S L terapia de células-tronco em patologias endometriais
JP2020532745A (ja) * 2017-09-05 2020-11-12 アイジェノミクス エセ．エレ． 子癇前症と関連したバイオマーカーを検出するための方法及び装置
CA3093206A1 (en) 2018-03-06 2019-09-12 Christine Metz Methods for detecting and treating endometriosis
CN114990038B (zh) * 2022-05-24 2023-06-27 郑州大学 一种细菌外膜囊泡及其在制备先兆子痫治疗药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712103A (en) * 1995-02-13 1998-01-27 Regents Of The University Of California Diagnostic assay for the prediction of preeclampsia
IL127896A0 (en) 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
WO2007030889A1 (en) * 2005-09-15 2007-03-22 Victor Voroteliak Method of diagnosing pre-eclampsia
WO2008134881A1 (en) * 2007-05-05 2008-11-13 The University Of Western Ontario Methods for the detection of preeclampsia
EP2019318A1 (en) * 2007-07-27 2009-01-28 Erasmus University Medical Center Rotterdam Protein markers for cardiovascular events
CN101290321A (zh) * 2008-04-11 2008-10-22 中国医学科学院肿瘤研究所 膜联蛋白a2的血清检测方法、检测试剂盒及其应用
US8673850B2 (en) 2008-05-30 2014-03-18 Institut De Recherches Cliniques De Montreal PCSK9 inhibitors and methods of use thereof
CN110187119B (zh) * 2008-10-31 2022-07-29 耶鲁大学 子痫前期检测和治疗的方法和组合物
US20120107825A1 (en) * 2010-11-01 2012-05-03 Winger Edward E Methods and compositions for assessing patients with reproductive failure using immune cell-derived microrna
JP2014507160A (ja) * 2011-02-22 2014-03-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． 循環バイオマーカー
US9423402B2 (en) * 2011-11-30 2016-08-23 Singapore Health Services Pte. Ltd. GM1 ganglioside to annexin V microparticle polypeptide ratio for biological monitoring
SG11201407667UA (en) * 2012-06-27 2015-02-27 Hoffmann La Roche MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD
CN103436552A (zh) * 2013-09-10 2013-12-11 浙江大学 一种人源annexin A2的生产方法及其应用

Also Published As

Publication number Publication date
WO2015166353A3 (en) 2016-01-21
JP2017513021A (ja) 2017-05-25
MX2016012278A (es) 2017-04-27
US20170097358A1 (en) 2017-04-06
BR112016021630A2 (pt) 2020-02-27
CN106662589A (zh) 2017-05-10
EP3120152A2 (en) 2017-01-25
JP6684263B2 (ja) 2020-04-22
WO2015166353A2 (en) 2015-11-05
CA2943284A1 (en) 2015-11-05
CN110927385A (zh) 2020-03-27
CN106662589B (zh) 2019-07-30

Similar Documents

Publication Publication Date Title
MX2021006791A (es) Metodos y composiciones para detectar proteinas mal plegadas.
MX390772B (es) Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias.
AR095363A1 (es) Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1
MX374652B (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.
BR112016027475A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático
MX2017003790A (es) Detección de secuencias diana por percepción de nanoporos de sondas sintéticas.
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
EP3800253A3 (en) Prostate cancer detection kit or device, and detection method
BR112016029583A2 (pt) ?kit ou dispositivo para a detecção de câncer esofágico e método de detecção?
MX387936B (es) Metodo para la cuantificacion de huevos de parasitos en las heces.
EP4060048A3 (en) Non-invasive diagnostic method for diagnosing bladder cancer
WO2015094996A3 (en) Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonists
BR112016002668A2 (pt) métodos e kits para prognosticar o risco de ter uma doença ou evento cardiovasculares
EA201790769A1 (ru) Определение уровней гликозаминогликанов методом масс-спектрометрии
WO2015131151A3 (en) Method and apparatus for determining markers of health by analysis of blood
EP3415912A4 (en) ANALYT DETECTION PROCEDURE AND REAGENT SET TO DETECT ANALYTES
MX2016009450A (es) Ensayo novedoso para detectar periostina humana.
EA201700208A1 (ru) Способ и устройство для обнаружения малярии
BR112016013976A2 (pt) método para determinar se um indivíduo é afetado por um câncer, método para discriminar entre câncer colorretal e pancreático dentre indivíduos que resultam ser positivos para o método, método para determinar o estágio de um câncer colorretal em um indivíduo afetado e uso de um kit de rt-pcr quantitativo para performar o método
WO2015166353A3 (en) Early detection of preeclampsia
MX377026B (es) Biomarcadores para la progresión de enfermedades en melanoma.
EP3430406A4 (en) METHOD FOR CANCER DIAGNOSIS AND PROGNOSIS
MA40636A (fr) Procédés pour détecter le cancer de la prostate
EP2937421A3 (en) Biomarker for predicting effect of an anti-C-met antibody
MX2015013993A (es) Procedimientos y series para su uso en los mismos.